COVID-19 test kit SC-1262-20

fluSARS-COV-2influenza A

The Covid-19 Antigen Rapid Swab and Influenza A + B (nasopharyngeal swab) is a rapid immunochromatographic test for the qualitative detection of the antigens of the Sars-CoV-2, Influenza A and Influenza B viruses present in the human nasopharynx. For professional in vitro diagnostic use only. The separate results indicate the detection of Sars-CoV-2 and Influenza A + B antigens. The antigen is generally detectable in upper respiratory tract samples during the acute phase of the infection. Positive results indicate the presence of viral antigens, but a clinical correlation with the patient’s medical history and other diagnostic information is required to determine the infectious state. The positive results do not exclude bacterial infection or co-infections with other viruses. The identified agent may not be the determining cause of the disease. The result is separate for Covid-19, Influenza A and Influenza B. The combined rapid test for COVID-19 antigens and influenza A + B (nasopharyngeal swab) is a rapid immunochromatographic test for the qualitative detection of the SARS-CoV-2 nucleocapsid protein , influenza A and influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2 / Influenza infection in combination with clinical presentation and other laboratory test results. The results indicate the identification of the SARS-CoV-2 nuclecapsid protein and Influenza A + B. The antigen is generally detectable in upper respiratory tract samples during the acute phase of the infection. Positive results indicate the presence of viral antigens, but a clinical correlation with the patient’s medical history